毒品类别
药品
班级(哲学)
二氢吡啶
医学
机制(生物学)
心力衰竭
药理学
重症监护医学
计算机科学
心脏病学
内科学
钙
人工智能
认识论
哲学
作者
Isabel Soares,António Vaz Carneiro
出处
期刊:PubMed
日期:2002-09-01
卷期号:21 (9): 1031-42
被引量:8
摘要
The concept of drug class effect is profoundly rooted in clinical practice. The use of drugs seen as similar in their clinical effects--and therefore interchangeable--is very frequent: two examples of this are the use of beta-blockers in arterial hypertension and angiotensin-converting enzyme (ACE) inhibitors in congestive heart failure. The definition of drug class effect is based on three concepts: a similar chemical structure (for example, the dihydropyridine ring of some calcium channel blockers), a similar mechanism of action (beta-blockers block adrenoreceptors), or similar pharmacological effects (antihypertensives, antianginals, etc.). In this article, we will describe the type of evidence that a cardiologist can use in order to select a specific drug (from within a class). It constitutes a clinical approach, different from the one that might be used by a third party payer (more interested in cost-effectiveness issues) or the pharmaceutical industry (more interested in promoting sales). As usual, the recommendations are based on the strength of scientific evidence.
科研通智能强力驱动
Strongly Powered by AbleSci AI